KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Current Assets (2020 - 2026)

Organon has reported Current Assets over the past 7 years, most recently at $4.9 billion for Q1 2026.

  • For Q1 2026, Current Assets rose 12.83% year-over-year to $4.9 billion; the TTM value through Mar 2026 reached $4.9 billion, up 12.83%, while the annual FY2025 figure was $4.4 billion, 0.09% changed from the prior year.
  • Current Assets for Q1 2026 was $4.9 billion at Organon, up from $4.4 billion in the prior quarter.
  • Over five years, Current Assets peaked at $4.9 billion in Q1 2026 and troughed at $3.6 billion in Q3 2022.
  • A 5-year average of $4.2 billion and a median of $4.3 billion in 2024 define the central range for Current Assets.
  • On a YoY basis, Current Assets climbed as much as 24.92% in 2022 and fell as far as 17.02% in 2022.
  • Year by year, Current Assets stood at $3.9 billion in 2022, then grew by 14.68% to $4.5 billion in 2023, then fell by 3.55% to $4.3 billion in 2024, then rose by 0.09% to $4.4 billion in 2025, then rose by 13.33% to $4.9 billion in 2026.
  • Business Quant data shows Current Assets for OGN at $4.9 billion in Q1 2026, $4.4 billion in Q4 2025, and $4.7 billion in Q3 2025.